Efficacy of once-daily Avelox for complicated abdominal infections highlighted at ICAAC

SAN FRANCISCO, Sept. 29, 2006 The efficacy of monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) in the treatment of complicated intra-abdominal infections (cIAI) was highlighted in two clinical data presentations by researchers here at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2006, Schering-Plough Corporation (NYSE: SGP) reported today.

Approximately 3.5 million Americans are diagnosed annually with cIAIs, which are caused by disease, trauma or surgery in the abdomen that can allow bacteria to leak from the gastrointestinal tract into adjacent tissue.(1)

"Complicated intra-abdominal infections often involve several different kinds of bacteria and require broad-spectrum antibiotic therapy for effective treatment," said Robert J. Spiegel, M.D., chief medical officer and senior vice president, Schering-Plough Research Institute. "The data presented at ICAAC further underscore the efficacy of once-daily AVELOX monotherapy in treating these infections."

AVELOX is the only marketed fluoroquinolone antibiotic approved by the U.S. Food and Drug Administration (FDA) as monotherapy to treat cIAI, and has been shown to be effective at eradicating the most common bacteria that cause cIAI, including E. coli and B. fragilis. AVELOX is indicated to treat polymicrobial cIAI infections, including infections caused by mixed aerobic and anaerobic bacteria (bacteria that thrive without oxygen) commonly seen in patients with cIAI.(2,3)


Contact: Trista Dawson
GCI Group

Page: 1

Related biology news :

1. Malaria: Efficacy of monotherapies in Cameroon
2. Avelox as effective as Levofloxacin combination therapy for severe community-acquired pneumonia
3. FDA approves AVELOX (moxifloxacin HCl) for treatment of complicated intra-abdominal infections
4. Hepatitis C complicated by morphine withdrawal
5. The simple truth: Animal development not as complicated as it seems
6. Scientists find that the human nose is more complicated than a jumbo jet
7. AVELOX as effective as multi-dose combination therapy for intra-abdominal infections
8. New research suggests abdominal aortic aneurysm will afflict millions of baby boomers
9. MRI excellent choice for overcoming challenges of diagnosing pregnant women with abdominal pain
10. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
11. Injection drug use and HIV and HCV infections among Ontario prison inmates

Post Your Comments:

(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, a ... announce that Eric Chen and Jessica Wong have joined the company’s leadership team ... respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, an ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval ... CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned a ... The company’s solutions are the first Wharton’s jelly allograft product to be recognized as ...
(Date:7/31/2020)... ... 30, 2020 , ... BioFactura, Inc. today announced a $1 ... Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense ... highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... , ... July 30, 2020 ... ... cloud-based software for the life sciences industry, today announced the release of ... designed specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, the ... is only the beginning of a successful study, while protecting and accessing the catheter ... Global Head of Surgery from Envigo in a live webinar ...
(Date:7/18/2020)... ... 16, 2020 , ... Medial EarlySign , a leader ... of high-burden diseases, and Centric Consulting, a business and technology consulting firm, today ... data in order to identify and prioritize patients for care. , Combining Centric’s ...
(Date:7/10/2020)... (PRWEB) , ... July 08, 2020 , ... ... services and products, announces a significant expansion of laboratory operations through its ... for agencies implementing testing programs. , Bode-CARES provides a turnkey ...
Breaking Biology Technology:
Cached News: